Enoki Hideo, Itamura Shinji, Baba Shimpei, Okanishi Tohru, Fujimoto Ayataka
Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Front Neurol. 2020 Dec 3;11:591477. doi: 10.3389/fneur.2020.591477. eCollection 2020.
Panayiotopoulos syndrome (PS) is a self-limited focal epilepsy appearing in childhood. Seizures in PS are self-limiting and do not usually continue into adulthood. Juvenile myoclonic epilepsy (JME) is the most common type of idiopathic generalized epilepsy, developing around puberty and continuing throughout adulthood. We describe four cases of PS in childhood in which JME developed in adolescence. Age at onset ranged from 4 to 8 years for PS, and 11 to 14 years for JME. JME developed after PS subsided, with the interval between last PS seizure and first JME seizure ranging from 1 to 10 years. No link between the two conditions has previously been described. Since PS is considered to show good prognosis and to be self-limiting, long-term observation has been considered unnecessary. No definitive factors were found to predict future evolution to JME in our series, so longer-term follow-up may be warranted for all PS patients.
帕纳约托普洛斯综合征(PS)是一种出现在儿童期的自限性局灶性癫痫。PS发作具有自限性,通常不会持续到成年期。青少年肌阵挛性癫痫(JME)是最常见的特发性全身性癫痫类型,在青春期左右发病并持续至成年期。我们描述了4例儿童期患PS且在青春期发展为JME的病例。PS的发病年龄为4至8岁,JME的发病年龄为11至14岁。JME在PS缓解后出现,最后一次PS发作与首次JME发作之间的间隔为1至10年。此前尚未描述这两种病症之间的关联。由于PS被认为预后良好且具有自限性,因此一直认为无需进行长期观察。在我们的系列研究中,未发现可预测未来发展为JME的决定性因素,所以或许应对所有PS患者进行更长时间的随访。